{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:28:00Z","timestamp":1787254080664,"version":"build-2736575974"},"reference-count":14,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["K23DK123384-03"],"award-info":[{"award-number":["K23DK123384-03"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>There is a need for improved glycemia monitoring tools for people with type 2 diabetes (T2D) and end-stage kidney failure (ESKF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>This prospective, randomized, crossover trial compared the efficacy of real-time continuous glucose monitoring (rtCGM) with capillary blood glucose (CBG) testing in adults with T2D and ESKF undergoing hemodialysis. The primary outcome was percentage of time below range (%TBR) &amp;lt;70 mg\/dL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The %TBR &amp;lt;70 mg\/dL was not significantly different between groups (mean 1.17% \u00b1 1.8 vs. 1.29% \u00b1 2.7; P = 0.28). Compared with CBG testing, percentage time in range (%TIR) was higher (63.4% \u00b1 24 vs. 54.5% \u00b1 23) and mean glucose lower (173.6 \u00b1 37 vs. 187.7 \u00b1 38 mg\/dL) after the rtCGM intervention, while percentage time above range (%TAR) &amp;gt;180 mg\/dL (35.3% \u00b1 25 vs. 44.3% \u00b1 23) and &amp;gt;250 mg\/dL decreased (12.3% \u00b1 15 vs. 18.8% \u00b1 19) (all P \u2264 0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In adults with T2D and ESKF undergoing hemodialysis, TBR was minimal and not influenced by rtCGM use. Compared with CBG testing, %TIR and %TAR improved during the rtCGM intervention. Future studies are needed to confirm the benefits of rtCGM in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0404","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:25:10Z","timestamp":1782483910000},"page":"1621-1626","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3225","authenticated-orcid":false,"given":"Rodolfo J.","family":"Galindo","sequence":"first","affiliation":[{"name":"Division of Endocrinology, University of Miami Miller School of Medicine 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobak","family":"Moazzami","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Emory University School of Medicine 2 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Gerges","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Emory University School of Medicine 2 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Flores","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Emory University School of Medicine 2 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Arevalo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Miami Miller School of Medicine 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Rollins School of Public Health, Emory University 3 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-7592","authenticated-orcid":false,"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Kidney Research Institute and Division of Nephrology, Department of Medicine, University of Washington 4 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[{"name":"Kidney Research Institute and Division of Nephrology, Department of Medicine, University of Washington 4 , Seattle, WA"},{"name":"Providence Medical Research Center, Providence Inland Northwest Health 5 , Spokane, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Emory University School of Medicine 2 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2026082014534027300_B1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2337\/dc21-1579","article-title":"Hypoglycemic and hyperglycemic crises among U.S. Adults with diabetes and end-stage kidney disease: population-based study, 2013\u20132017","volume":"45","author":"Galindo","year":"2022","journal-title":"Diabetes Care"},{"key":"2026082014534027300_B2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic monitoring and management in advanced chronic kidney disease","volume":"41","author":"Galindo","year":"2020","journal-title":"Endocr Rev"},{"key":"2026082014534027300_B3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00125-024-06244-y","article-title":"Diabetes technology in people with diabetes and advanced chronic kidney disease","volume":"67","author":"Galindo","year":"2024","journal-title":"Diabetologia"},{"key":"2026082014534027300_B4","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"2026082014534027300_B5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"2026082014534027300_B6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/19322968241292041","article-title":"Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes","volume":"19","author":"Rhee","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"2026082014534027300_B7","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/clinem\/dgaf187","article-title":"Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes","volume":"110","author":"Galindo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026082014534027300_B8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1681\/ASN.0000000693","article-title":"Glycemia assessed by continuous glucose monitoring among people treated with maintenance dialysis","volume":"36","author":"de Boer","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026082014534027300_B9","first-page":"527","article-title":"Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial","volume":"27","author":"Bergenstal","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"2026082014534027300_B10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2337\/dc22-0073","article-title":"Accuracy of a factory-calibrated continuous glucose monitor in individuals with diabetes on hemodialysis","volume":"45","author":"Villard","year":"2022","journal-title":"Diabetes Care"},{"key":"2026082014534027300_B11","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2337\/dc24-0635","article-title":"Accuracy of continuous glucose monitoring in hemodialysis patients with diabetes","volume":"47","author":"Narasaki","year":"2024","journal-title":"Diabetes Care"},{"key":"2026082014534027300_B12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2337\/dc23-1276","article-title":"Assessment of glycemic control by continuous glucose monitoring, hemoglobin A1c, Fructosamine, and glycated albumin in patients with end-stage kidney disease and burnt-out diabetes","volume":"47","author":"Kaminski","year":"2024","journal-title":"Diabetes Care"},{"key":"2026082014534027300_B13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/dia.2024.0145","article-title":"Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis","volume":"26","author":"Galindo","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026082014534027300_B14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/15209156251368934","article-title":"Accuracy of Dexcom G6 Pro and G7 continuous glucose monitors in patients treated with maintenance dialysis","volume":"28","author":"Zelnick","year":"2026","journal-title":"Diabetes Technol Ther"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1621\/887814\/dc260404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1621\/887814\/dc260404.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:53:49Z","timestamp":1787252029000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/9\/1621\/172120\/Real-Time-Continuous-Glucose-Monitoring-Among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":14,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,6,26]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0404","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}